Skip to main content

Diabetes

mHBOT Studies & Research

Mild hyperbaric oxygen inhibits the growth-related decline in skeletal muscle oxidative capacity and prevents hyperglycemia in rats with type 2 diabetes mellitus

Keywords: Myogenic Regulatory Factors

Title: Mild hyperbaric oxygen inhibits the growth-related decline in skeletal muscle oxidative capacity and prevents hyperglycemia in rats with type 2 diabetes mellitus

Publisher: Journal of Diabetes (Print: Volume 10, Issue 9, 689-771, Sept. 2018) (Online: 04/06/2018)

Pressure: 1.25 ATA

Oxygen Concentration: 36%

Duration: 180 min

Sessions: 154

Conclusion: Exposure to mild hyperbaric oxygen inhibits the decline in skeletal muscle oxidative capacity and prevents the hyperglycemia associated with T2DM. Pgc-1α, Myog, and Myf5 mRNA levels appear to be closely associated with skeletal muscle oxidative capacity in rats with T2DM.

Read the full study.

Effects of hyperbaric oxygen on metabolic capacity of the skeletal muscle in type 2 diabetic rats with obesity

Keywords: Metabolic Capacity

Title: Effects of hyperbaric oxygen on metabolic capacity of the skeletal muscle in type 2 diabetic rats with obesity

Publisher: The Scientific World Journal (Print: Volume 2012) (Online: 06/18/2012)

Pressure: 1.25 ATA

Oxygen Concentration: 36%

Duration: 180 min

Sessions: 154

Conclusion: Hyperbaric oxygen enhances glucose and lipid metabolism in the skeletal muscle, indicating that hyperbaric oxygen can prevent elevation of glucose and adipocyte hypertrophy in diabetic rats with obesity.

Read the full study.

Effect of exposure to hyperbaric oxygen on diabetes-induced cataracts in mice

Keywords: Cateract

Title: Effect of exposure to hyperbaric oxygen on diabetes-induced cataracts in mice

Publisher: Journal of Diabetes (Print: Volume 3, Issue 4, 257-356, Dec. 2011) (Online: 08/01/2011)

Pressure: 1.25 ATA

Oxygen Concentration: 36%

Duration: 360 min

Sessions: 84

Conclusion:

Hyperbaric exposure at 1.25 ata with 36% oxygen delays cataract development and progression in mice with Type 2 diabetes.

Read the full study.

Disclaimer: Statements, testimonials, and services provided by Renewal Care, LLC are not intended to diagnose, treat, cure or prevent any disease or illness. [more]

Nothing on this site is to be construed as medical advice; the authors are not doctors. The testimonials and feedback received are voluntarily provided and do not necessarily represent the views of this company. They have not been evaluated by the Food and Drug Administration and are not intended to be a substitute for professional medical advice, diagnosis or treatment. Any recommendations made by Renewal Care, LLC do not constitute as a medical recommendation and are intended for informational and educational purposes only, and no claims (real or implied) are being made. While studies support the use and effectiveness of the available therapies when used to help an individual facing various medical conditions, individual results may vary and it is the responsibility of the client to do their own personal due diligence; always ask your doctor about all treatment options, including all risks and benefits. Renewal Care, LLC is not a health care provider. Please discuss your personal health, including any options or ideas you may read on the internet (on this site or others) with your personal, qualified health practitioner before making changes to your lifestyle, diet, treatments, therapies or adjusting/discontinuing use of any medication.